ATE491026T1 - Ply-gbs-lysinmutanten - Google Patents
Ply-gbs-lysinmutantenInfo
- Publication number
- ATE491026T1 ATE491026T1 AT06813511T AT06813511T ATE491026T1 AT E491026 T1 ATE491026 T1 AT E491026T1 AT 06813511 T AT06813511 T AT 06813511T AT 06813511 T AT06813511 T AT 06813511T AT E491026 T1 ATE491026 T1 AT E491026T1
- Authority
- AT
- Austria
- Prior art keywords
- gbs
- plygbs
- streptococci
- lysins
- bacteria
- Prior art date
Links
- 239000004472 Lysine Substances 0.000 title 1
- 241000894006 Bacteria Species 0.000 abstract 3
- 230000001580 bacterial effect Effects 0.000 abstract 2
- 230000002147 killing effect Effects 0.000 abstract 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
- 230000002101 lytic effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71093605P | 2005-08-24 | 2005-08-24 | |
| PCT/US2006/032176 WO2007024628A2 (en) | 2005-08-24 | 2006-08-17 | Ply-gbs mutant lysins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE491026T1 true ATE491026T1 (de) | 2010-12-15 |
Family
ID=37772174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06813511T ATE491026T1 (de) | 2005-08-24 | 2006-08-17 | Ply-gbs-lysinmutanten |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8105585B2 (de) |
| EP (2) | EP2360248A1 (de) |
| JP (1) | JP2009506033A (de) |
| CN (1) | CN101297034A (de) |
| AT (1) | ATE491026T1 (de) |
| CA (1) | CA2620903A1 (de) |
| DE (1) | DE602006018746D1 (de) |
| ES (1) | ES2357626T3 (de) |
| WO (1) | WO2007024628A2 (de) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008018854A2 (en) * | 2005-06-06 | 2008-02-14 | The Rockefeller University | Bactiophage lysins for bacillus anthracis |
| CN101297034A (zh) | 2005-08-24 | 2008-10-29 | 洛克菲勒大学 | Ply-gbs突变溶素 |
| WO2010002959A2 (en) * | 2008-07-03 | 2010-01-07 | The Rockefeller University | A chimeric bacteriophage lysin with activity against staphylococci bacteria |
| MX383544B (es) | 2011-04-21 | 2025-03-14 | Univ Rockefeller | Lisinas de bacteriofago de streptococcus para la deteccion y tratamiento de bacterias gram positivas |
| CA2851270C (en) | 2011-10-05 | 2023-03-14 | The Rockefeller University | Dimeric bacteriophage lysins |
| CN102516398B (zh) * | 2011-12-27 | 2014-07-16 | 中国科学院遗传与发育生物学研究所 | 抗乳房炎转基因小鼠模型的构建方法及其专用载体 |
| RU2646102C2 (ru) | 2012-05-09 | 2018-03-01 | Контрафект Корпорейшн | Предотвращение, разрушение и обработка биопленки лизином бактериофага |
| AU2013259512B2 (en) | 2012-05-09 | 2018-01-25 | Contrafect Corporation | Bacteriophage lysin and antibiotic combinations against gram positive bacteria |
| DE102013106455A1 (de) | 2013-06-20 | 2014-12-24 | Airbus Defence and Space GmbH | Verfahren zur Dekontamination von bakteriologischen Verunreinigungen |
| CN109152822B (zh) | 2016-05-12 | 2023-12-05 | 抗非特公司 | 用于评估和确定抗菌多肽的最小抑制浓度的肉汤微量稀释法 |
| CN107083434B (zh) * | 2017-06-05 | 2020-09-08 | 武汉赛思锐微生物技术有限公司 | 一种非诊断目的的荧光pcr定量检测b族链球菌的样本前处理方法 |
| EA202090748A1 (ru) * | 2017-06-16 | 2020-08-11 | Борис Славинович ФАРБЕР | Биологически активные комбинаторные производные полисахаридов |
| EP3771463A1 (de) * | 2019-07-29 | 2021-02-03 | Ludwig-Maximilians-Universität München | Stabilisierung therapeutischer proteine mit piperazin- oder morpholinhaltigen zwitterionischen puffersubstanzen |
| CN112501189A (zh) * | 2020-12-30 | 2021-03-16 | 吉林大学 | 一种能杀死马链球菌马亚种的裂解酶及其医用用途 |
| KR102713606B1 (ko) * | 2022-07-26 | 2024-10-10 | 주식회사 인트론바이오테크놀로지 | 젖소유방염 치료용 항균단백질 조성물 |
| KR102742550B1 (ko) * | 2022-07-26 | 2024-12-18 | 주식회사 인트론바이오테크놀로지 | 연쇄상구균에 대하여 용균 활성을 갖는 항균단백질 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| JPS6023084B2 (ja) | 1979-07-11 | 1985-06-05 | 味の素株式会社 | 代用血液 |
| US4640835A (en) | 1981-10-30 | 1987-02-03 | Nippon Chemiphar Company, Ltd. | Plasminogen activator derivatives |
| JPH0830004B2 (ja) | 1983-11-14 | 1996-03-27 | コロンビア ラボラトリーズ インコーポレイテッド | 生物接着性組成物およびそれにより治療する方法 |
| US4496689A (en) * | 1983-12-27 | 1985-01-29 | Miles Laboratories, Inc. | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer |
| DE3587814T2 (de) * | 1985-03-30 | 1994-11-10 | Marc Ballivet | Verfahren zum erhalten von dns, rns, peptiden, polypeptiden oder proteinen durch dns-rekombinant-verfahren. |
| EP0206448B1 (de) | 1985-06-19 | 1990-11-14 | Ajinomoto Co., Inc. | Hämoglobin, das an ein Poly(alkenylenoxid) gebunden ist |
| US4680338A (en) * | 1985-10-17 | 1987-07-14 | Immunomedics, Inc. | Bifunctional linker |
| JPS63502716A (ja) | 1986-03-07 | 1988-10-13 | マサチューセッツ・インステチュート・オブ・テクノロジー | 糖タンパク安定性の強化方法 |
| US4791192A (en) * | 1986-06-26 | 1988-12-13 | Takeda Chemical Industries, Ltd. | Chemically modified protein with polyethyleneglycol |
| US4948580A (en) | 1988-12-08 | 1990-08-14 | E. R. Squibb & Sons, Inc. | Muco-bioadhesive composition |
| US5225538A (en) | 1989-02-23 | 1993-07-06 | Genentech, Inc. | Lymphocyte homing receptor/immunoglobulin fusion proteins |
| JPH02258718A (ja) | 1989-03-31 | 1990-10-19 | Nippon Kayaku Co Ltd | ペースト状基剤及び製剤 |
| US5264563A (en) * | 1990-08-24 | 1993-11-23 | Ixsys Inc. | Process for synthesizing oligonucleotides with random codons |
| JPH08503950A (ja) | 1992-12-02 | 1996-04-30 | アルカーメス・コントロールド・セラピユーテイクス・インコーポレーテツド | 徐放性成長ホルモン含有マイクロスフェア |
| US5605793A (en) * | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US5554380A (en) | 1994-08-04 | 1996-09-10 | Kv Pharmaceutical Company | Bioadhesive pharmaceutical delivery system |
| EP1002529A1 (de) | 1994-09-09 | 2000-05-24 | Takeda Chemical Industries, Ltd. | Zubereitung mit verzögerter Freigabe eines Metallsalz eines Peptids |
| SK281571B6 (sk) | 1995-06-07 | 2001-05-10 | Alkermes Controlled Therapeutics, Inc. | Prostriedok na trvalé uvoľňovanie ľudského rastového hormónu |
| ZA965368B (en) | 1995-07-14 | 1997-01-14 | Novo Nordisk As | A pharmaceutical formulation |
| US5863560A (en) * | 1996-09-11 | 1999-01-26 | Virotex Corporation | Compositions and methods for topical application of therapeutic agents |
| US5942243A (en) * | 1996-11-12 | 1999-08-24 | Polytherapeutics, Inc. | Mucoadhesive compositions for administration of biologically active agents to animal tissue |
| US6056954A (en) * | 1997-10-31 | 2000-05-02 | New Horizons Diagnostics Corp | Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses |
| US6056955A (en) * | 1999-09-14 | 2000-05-02 | Fischetti; Vincent | Topical treatment of streptococcal infections |
| EP1501925A4 (de) * | 2002-05-17 | 2006-10-25 | New Horizons Diagnostics Corp | Identifizierung eines phagenassoziierten lytischen enzyms zum schnellen und spezifischen nachweisen und abtöten von bacillus anthracis |
| US20040081646A1 (en) * | 2002-08-29 | 2004-04-29 | Engler Jeffrey A. | Group B Streptococcal phage lysin |
| US7569223B2 (en) * | 2004-03-22 | 2009-08-04 | The Rockefeller University | Phage-associated lytic enzymes for treatment of Streptococcus pneumoniae and related conditions |
| US7638600B2 (en) * | 2004-03-24 | 2009-12-29 | The Rockefeller University | Lytic enzymes and spore surface antigen for detection and treatment of Bacillus anthracis bacteria and spores |
| US7582291B2 (en) * | 2005-06-30 | 2009-09-01 | The Rockefeller University | Bacteriophage lysins for Enterococcus faecalis, Enterococcus faecium and other bacteria |
| CN101297034A (zh) | 2005-08-24 | 2008-10-29 | 洛克菲勒大学 | Ply-gbs突变溶素 |
| WO2010002959A2 (en) | 2008-07-03 | 2010-01-07 | The Rockefeller University | A chimeric bacteriophage lysin with activity against staphylococci bacteria |
-
2006
- 2006-08-17 CN CNA2006800394859A patent/CN101297034A/zh active Pending
- 2006-08-17 JP JP2008527998A patent/JP2009506033A/ja active Pending
- 2006-08-17 AT AT06813511T patent/ATE491026T1/de not_active IP Right Cessation
- 2006-08-17 EP EP10191784A patent/EP2360248A1/de not_active Withdrawn
- 2006-08-17 DE DE602006018746T patent/DE602006018746D1/de not_active Expired - Lifetime
- 2006-08-17 WO PCT/US2006/032176 patent/WO2007024628A2/en not_active Ceased
- 2006-08-17 CA CA002620903A patent/CA2620903A1/en not_active Abandoned
- 2006-08-17 US US12/064,428 patent/US8105585B2/en active Active
- 2006-08-17 ES ES06813511T patent/ES2357626T3/es not_active Expired - Lifetime
- 2006-08-17 EP EP06813511A patent/EP1917355B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE602006018746D1 (de) | 2011-01-20 |
| CN101297034A (zh) | 2008-10-29 |
| ES2357626T3 (es) | 2011-04-28 |
| CA2620903A1 (en) | 2007-03-01 |
| EP1917355A2 (de) | 2008-05-07 |
| WO2007024628A3 (en) | 2007-06-14 |
| JP2009506033A (ja) | 2009-02-12 |
| EP2360248A1 (de) | 2011-08-24 |
| US8105585B2 (en) | 2012-01-31 |
| US20080221035A1 (en) | 2008-09-11 |
| EP1917355B1 (de) | 2010-12-08 |
| EP1917355A4 (de) | 2009-05-27 |
| WO2007024628A2 (en) | 2007-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602006018746D1 (de) | Ply-gbs-lysinmutanten | |
| DE602005012276D1 (de) | Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut | |
| TW200507841A (en) | Antibacterial agents | |
| AU2003291227A1 (en) | Antibacterial agents | |
| TW200806317A (en) | Methods for reducing protein aggregation | |
| DE60215494D1 (de) | Bicyclische, stickstoffhaltige heterocyclische derivate zur verwendung als antibakterielle mittel | |
| UA93384C2 (ru) | Способ получения стерилизированного порошкообразного панкреатина | |
| DE60216614D1 (de) | Zusammensetzung mit bakteriostatischen und bakteriziden eigenschaften gegen bakterielle sporen und zellen und verfahren zu deren verwendung zur behandlung von lebensmitteln | |
| TW200716200A (en) | Methods of reducing microbial contamination | |
| TW200621256A (en) | Formulations | |
| WO2005072826A3 (en) | Compositions and use of tyrosine kinase inhibitors to treat pathogenic infection | |
| EP1560821B8 (de) | Antibakterielle wirkstoffe | |
| NO20082425L (no) | Formuleringer omfattende jorumycin-, reni-eramycin-, safracin- eller saframycin-relaterte forbindelser for behandling av proliferative sykdommer | |
| WO2006081289A3 (en) | Antibacterial agents | |
| NO20072890L (no) | Behandling av mastitt | |
| WO2006081182A3 (en) | Antibacterial agents | |
| EA200400197A1 (ru) | Способы получения поливалентных бактериофагов для лечения бактериальных инфекций | |
| WO2007047608A3 (en) | Fibrin targeted therapeutics | |
| EP1781669A4 (de) | Antibakterielle mittel | |
| WO2006081178A3 (en) | Antibacterial agents | |
| IL194353A0 (en) | Lysobactin amides | |
| ATE433459T1 (de) | Desoxo-nonadepsipeptide | |
| MX2007011381A (es) | Composicion de espirulinas rica en principios activos, su proceso de obtencion y su utilizacion. | |
| DE60041198D1 (de) | Antimikrobielle zusammensetzungen | |
| ATE455789T1 (de) | Substituierte nonadepsipeptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |